targeted radiotherapy endoradiotherapy appealing approach cancer treatment potential delivering curative doses radiation tumor sparing normal tissues radionuclides decay emission heavy halogen 211at offer exciting prospect combining molecular targets radiation having range tissue cell diameters radiobiological advantages targeted radiotherapy reviewed rationale using 211at purpose described chemistry astatine similar iodine important differences make synthesis evaluation compounds challenging successful approach developed involves astatodemetallation tin silicon mercury precursors labeled agents investigated targeted radiotherapy include 211atastatide labeled particulates naphthoquinone derivatives methylene blue dna precursors biotin conjugates bisphosphonates antibodies antibody fragments status compounds discussed terms labeling chemistry cytotoxicity cell culture tissue distribution therapeutic efficacy animal models human cancers finally update status clinical trial targeted therapeutic 211atlabeled chimeric antibody 81c6 provided references NUMBER alpha particles astatine NUMBER cell specific alpha particle 211at labeled astatine NUMBER 211at 211at labeled 211at labeled 211at labeled meta 211atastatobenzylguanidine 211at labeled 211at labeled 211at labeled 211at labeled 211at labeled anti tenascin